| FWMIX | PLVIX | FWMIX / PLVIX | |
| Total Expense Ratio | 0.26 | 0.69 | 38% |
| Annual Report Gross Expense Ratio | 0.26 | 0.71 | 37% |
| Fund Existence | 9 years | 25 years | - |
| Gain YTD | 8.339 | -7.842 | -106% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 209B | 2.46B | 8,499% |
| Annual Yield % from dividends | 1.42 | 1.22 | 116% |
| Returns for 1 year | 6.49 | -8.99 | -72% |
| Returns for 3 years | 33.27 | 6.90 | 482% |
| Returns for 5 years | 42.59 | 6.67 | 639% |
| Returns for 10 years | N/A | 37.65 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYVYX | 687.10 | 3.50 | +0.51% |
| Rydex NASDAQ-100® 2x Strategy H | |||
| AMGOX | 24.30 | 0.10 | +0.41% |
| Alger Mid Cap Growth I-2 | |||
| JHDAX | 20.04 | 0.05 | +0.25% |
| JPMorgan Hedged Equity 2 A | |||
| ANTUX | 10.18 | 0.02 | +0.20% |
| American Century Non-US IntrsVal Inv | |||
| EEMDX | 9.95 | -0.01 | -0.10% |
| MFS Emerging Markets Equity Research R1 | |||